Self-nanoemulsifying drug delivery systems (SNEDDS) were developed and tested for efficient ocular delivery of Sirtuin-1 (SIRT-1) agonists, resveratrol (RSV), and melatonin, for potential applications in diabetic retinopathy treatment. Here, SIRT1 is linked to diabetic retinopathy.